In CRC, the number of CD166 positive specimens with nucleotide change is 6 (6/12 = 50.0%) whereas the number of CD166 negative specimens with nucleotide change is 2 (2/6 = 33.3%). Here, ALCAM is linked to colorectal carcinoma.